Meeder Advisory Services’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$146K Sell
31,431
-656
-2% -$3.42K 0.01% 672
2025
Q4
$160K Sell
32,087
-217
-0.7% -$1.13K 0.01% 654
2025
Q3
$164K Sell
32,304
-2,806
-8% -$12.4K 0.01% 606
2025
Q2
$151K Sell
35,110
-3,299
-9% -$16.3K 0.01% 597
2025
Q1
$232K Sell
38,409
-278
-0.7% -$1.41K 0.01% 515
2024
Q4
$153K Sell
38,687
-15,102
-28% -$67.6K 0.01% 543
2024
Q3
$315K Sell
53,789
-1,521
-3% -$7.5K 0.02% 422
2024
Q2
$238K Buy
55,310
+17,375
+46% +$83.3K 0.02% 455
2024
Q1
$178K Buy
37,935
+19,407
+105% +$74.3K 0.02% 438
2023
Q4
$91K Buy
18,528
+3,787
+26% +$18.5K 0.01% 420
2023
Q3
$80.3K Buy
14,741
+3,771
+34% +$30.2K 0.01% 401
2023
Q2
$102K Buy
+10,970
New +$92.8K 0.01% 429

Other funds holding MPT

Meeder Advisory Services's MPT Position: Q1 2026 in Review

Meeder Advisory Services reduced its Medical Properties Trust (MPT) stake by 2% in Q1 2026, selling an estimated $3.42K and leaving 31,431 shares worth $146K. The position accounts for 0.01% of the portfolio, ranked #672.

Meeder Advisory Services first reported a position in MPT in Q2 2023 and has held it in 12 quarters since. The position peaked at $315K in Q3 2024. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Meeder Advisory Services held 31,431 shares of Medical Properties Trust worth $146K as of Q1 2026.
  • Meeder Advisory Services sold 656 Medical Properties Trust shares in Q1 2026, an estimated $3.42K.
  • Medical Properties Trust made up 0.01% of Meeder Advisory Services's portfolio in Q1 2026, its #672 holding.
  • Meeder Advisory Services first reported a position in Medical Properties Trust in Q2 2023 and has held it in 12 quarters since.
  • Meeder Advisory Services's Medical Properties Trust position peaked at $315K in Q3 2024.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.